Related references
Note: Only part of the references are listed.Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
Yoshihiko Tomita et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)
Pan-cancer analysis of prognostic metastatic phenotypes
Nicholas G. Zaorsky et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Practice Patterns and Perioperative Outcomes of Laparoscopic Pancreaticoduodenectomy in China A Retrospective Multicenter Analysis of 1029 Patients
Min Wang et al.
ANNALS OF SURGERY (2021)
Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center Optimization of Operative Procedure and a Retrospective Study
Yusheng Shi et al.
ANNALS OF SURGERY (2021)
Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma
Hordur Kolbeinsson et al.
SURGERY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery
Ginimol Mathew et al.
INTERNATIONAL JOURNAL OF SURGERY (2021)
Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
Xiu-Ping Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
Kai Chen et al.
EBIOMEDICINE (2021)
Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
Masafumi Imamura et al.
CANCERS (2021)
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Xiaofei Zhu et al.
LANCET ONCOLOGY (2021)
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
Yu Wang et al.
CELL DISCOVERY (2021)
Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer
Xiaoqin Ji et al.
FRONTIERS IN ONCOLOGY (2021)
Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors
Naru Kim et al.
CANCERS (2020)
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Ming-Da Wang et al.
ONCOLOGIST (2020)
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma
Seoung Yoon Rho et al.
SCIENTIFIC REPORTS (2019)
Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
A Therapeutic Strategy for Resectable Pancreatic Cancer Based on Risk Factors of Early Recurrence
Hiroshi Kurahara et al.
PANCREAS (2018)
Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer
Shuji Suzuki et al.
EUROPEAN SURGICAL RESEARCH (2018)
Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective
John F. Ryan et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Preoperative predictors for early recurrence of resectable pancreatic cancer
Kohei Nishio et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Concepts and definitions for supportive care, best supportive care, palliative care, and hospice care in the published literature, dictionaries, and textbooks
David Hui et al.
SUPPORTIVE CARE IN CANCER (2013)
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
A. Van den Broeck et al.
EJSO (2009)
One thousand consecutive pancreaticoduodenectomies
JL Cameron et al.
ANNALS OF SURGERY (2006)
Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head
H Ohigashi et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)